GDNF gene therapy in the N171-82Q transgenic mouse model of Huntington's disease

被引：0
|
作者：
McBride, JL
Ramaswamy, S
Bartus, RT
Gasmi, M
Brandon, E
Zhou, L
Barry-Kravis, E
Pitzer, MR
Chen, E
Kordower, JH
机构：
[1] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA
[2] Ceregene Inc, San Diego, CA USA
[3] Dominican Univ, Dept Psychol, River Forest, IL 60305 USA
来源：
EXPERIMENTAL NEUROLOGY | 2005年 / 193卷 / 01期
关键词：
D O I：
暂无
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
引用
收藏
页码：253 / 253
页数：1
相关论文
共 50 条
  • [1] GDNF gene therapy in the N171-82Q transgenic mouse model of Huntington's disease.
    McBride, JL
    Ramaswamy, S
    Kordower, JH
    [J]. EXPERIMENTAL NEUROLOGY, 2004, 187 (01) : 214 - 214
  • [2] Cognitive deficits in the N171-82Q transgenic mouse model of Huntington's disease
    Ramaswamy, S
    McBride, JL
    Herzog, C
    Gasmi, M
    Brandon, E
    Bartus, R
    Zhou, L
    Berry-Kravis, E
    Kodower, JH
    [J]. EXPERIMENTAL NEUROLOGY, 2005, 193 (01) : 257 - 257
  • [3] Neuroprotective effects of phenylbutyrate in the N171-82Q transgenic mouse model of Huntington's disease
    Gardian, G
    Browne, SE
    Choi, DK
    Klivenyi, P
    Gregorio, J
    Kubilus, JK
    Ryu, H
    Langley, B
    Ratan, RR
    Ferrante, RJ
    Beal, MF
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (01) : 556 - 563
  • [4] The effect of CDNF on N171-82Q mouse model of Huntington's disease
    Stepanova, P.
    Lindholm, D.
    Voutilainen, M. H.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2019, 29 : S130 - S130
  • [5] Altered selenium status in Huntington's disease: Neuroprotection by selenite in the N171-82Q mouse model
    Lu, Zhen
    Marks, Eileen
    Chen, Jianfang
    Moline, Jenna
    Barrows, Lorraine
    Raisbeck, Merl
    Volitakis, Irene
    Cherny, Robert A.
    Chopra, Vanita
    Bush, Ashley I.
    Hersch, Steven
    Fox, Jonathan H.
    [J]. NEUROBIOLOGY OF DISEASE, 2014, 71 : 34 - 42
  • [6] Sertraline slows disease progression and increases neurogenesis in N171-82Q mouse model of Huntington's disease
    Duan, Wenzhen
    Peng, Qi
    Masuda, Naoki
    Ford, Eric
    Tryggestad, Erik
    Ladenheim, Bruce
    Zhao, Ming
    Cadet, Jean Lud
    Wong, John
    Ross, Christopher A.
    [J]. NEUROBIOLOGY OF DISEASE, 2008, 30 (03) : 312 - 322
  • [7] Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
    Jin, Jing
    Albertz, Jennifer
    Guo, Zhihong
    Peng, Qi
    Rudow, Gay
    Troncoso, Juan C.
    Ross, Christopher A.
    Duan, Wenzhen
    [J]. JOURNAL OF NEUROCHEMISTRY, 2013, 125 (03) : 410 - 419
  • [8] Tiagabine is neuroprotective in the N171-82Q and R6/2 mouse models of Huntington's disease
    Masuda, Naoki
    Peng, Qi
    Li, Qing
    Jiang, Mai
    Liang, Yideng
    Wang, Xiaofang
    Zhao, Ming
    Wang, Wenfei
    Ross, Christopher A.
    Duan, Wenzhen
    [J]. NEUROBIOLOGY OF DISEASE, 2008, 30 (03) : 293 - 302
  • [9] Structural MRI detects progressive regional brain atrophy and neuroprotective effects in N171-82Q Huntington's disease mouse model
    Cheng, Yong
    Peng, Qi
    Hou, Zhipeng
    Aggarwal, Manisha
    Zhang, Jiangyang
    Mori, Susumu
    Ross, Christopher A.
    Duan, Wenzhen
    [J]. NEUROIMAGE, 2011, 56 (03) : 1027 - 1034
  • [10] Beneficial behavioral effects of chronic cerebral dopamine neurotrophic factor (CDNF) infusion in the N171-82Q transgenic model of Huntington's disease
    Stepanova, P.
    Kumar, D.
    Cavonius, K.
    Korpikoski, J.
    Sirjala, J.
    Lindholm, D.
    Voutilainen, M. H.
    [J]. SCIENTIFIC REPORTS, 2023, 13 (01)
12345